These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12660133)

  • 1. [Economic assessment of adjuvant and palliative chemotherapy in colorectal cancer: a review].
    Selke B; Lebrun T; Comte S
    Bull Cancer; 2003 Feb; 90(2):143-9. PubMed ID: 12660133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cetuximab as First-line Treatment for Metastatic Colorectal Cancer: Caution With Interpretation of Cost-Effectiveness Results Toward Medical Decision Making.
    Franken MD; Koopman M; van Oijen MG
    Am J Clin Oncol; 2016 Apr; 39(2):214. PubMed ID: 26999056
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chemotherapy for colorectal cancers].
    Lièvre A; Mitry E
    J Chir (Paris); 2003 Feb; 140(1):52-5. PubMed ID: 12709655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Advances in palliative and adjuvant chemotherapy of colon cancer].
    Scheithauer W
    Dtsch Med Wochenschr; 2004 Oct; 129(40):2118-21. PubMed ID: 15455304
    [No Abstract]   [Full Text] [Related]  

  • 5. An economic evaluation of Tomudex (raltitrexed) and 5-fluorouracil plus leucovorin in advanced colorectal cancer.
    Groener MG; van Ineveld BM; Byttebier G; van Hout BA; Rutten FF
    Anticancer Drugs; 1999 Mar; 10(3):283-8. PubMed ID: 10327033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
    Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New chemotherapies for colorectal cancer treatment].
    Louvet C
    Gastroenterol Clin Biol; 2001 Apr; 25(4 Suppl):B51-6. PubMed ID: 11449145
    [No Abstract]   [Full Text] [Related]  

  • 8. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer.
    Vaiani M; Trippoli S; Messori A
    N Engl J Med; 2001 Jan; 344(4):305-6; author reply 306-7. PubMed ID: 11191660
    [No Abstract]   [Full Text] [Related]  

  • 9. Economic impact of simplified de Gramont regimen in first-line therapy in metastatic colorectal cancer.
    Limat S; Bracco-Nolin CH; Legat-Fagnoni C; Chaigneau L; Stein U; Huchet B; Pivot X; Woronoff-Lemsi MC
    Eur J Health Econ; 2006 Jun; 7(2):107-13. PubMed ID: 16474968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palliative treatment of patients with colorectal cancer.
    Glimelius B
    Scand J Surg; 2003; 92(1):74-83. PubMed ID: 12705554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent advance in chemotherapy for advanced colorectal cancer].
    Aiba K
    Gan To Kagaku Ryoho; 1996 Apr; 23(5):535-48. PubMed ID: 8678510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy (5-fluorouracil and levamisole) in Dukes' B and C colorectal carcinoma. A cost-effectiveness analysis.
    Norum J; Vonen B; Olsen JA; Revhaug A
    Ann Oncol; 1997 Jan; 8(1):65-70. PubMed ID: 9093709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and economic evaluation of first-line therapy with FOLFIRI or modified FOLFOX6 for metastatic colorectal cancer.
    Ajima H; Ogata H; Fujita K; Miwa K; Sunakawa Y; Mizuno K; Ishida H; Yamashita K; Nakayama H; Kawara K; Takahashi H; Sasaki Y
    Jpn J Clin Oncol; 2010 Jul; 40(7):634-8. PubMed ID: 20587616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current treatment options for advanced colorectal cancer.
    Rougier P; Mitry E
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):30-3. PubMed ID: 11049030
    [No Abstract]   [Full Text] [Related]  

  • 15. A Markov model assessing the effectiveness and cost-effectiveness of FOLFOX compared with FOLFIRI for the initial treatment of metastatic colorectal cancer.
    Tumeh JW; Shenoy PJ; Moore SG; Kauh J; Flowers C
    Am J Clin Oncol; 2009 Feb; 32(1):49-55. PubMed ID: 19194125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination chemotherapy and colorectal cancer.
    Sumpter K; Cunningham D
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):105-11. PubMed ID: 11049041
    [No Abstract]   [Full Text] [Related]  

  • 17. New therapies, new directions: advances in the systemic treatment of metastatic colorectal cancer.
    Holen KD; Saltz LB
    Lancet Oncol; 2001 May; 2(5):290-7. PubMed ID: 11905784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug clinics. How I treat. II. Therapeutic approaches to metastatic colorectal cancer].
    Jerusalem G; Bours V; Fillet G
    Rev Med Liege; 1998 Jun; 53(6):318-21. PubMed ID: 9713208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adjuvant and palliative chemotherapy of colorectal cancer in Germany outside controlled trials].
    Lamberti C; Lundin S; Bogdanow M; Gorschlüter M; Schmidt-Wolf IG; Sauerbruch T
    Dtsch Med Wochenschr; 2006 Mar; 131(10):485-90. PubMed ID: 16511737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-minimization analysis of sequence changes between FOLFIRI and FOLFOX6 therapy for advanced colorectal cancer in Japan.
    Miyazaki Y; Harada T; Akase T; Arakawa I; Inoue T
    Clin Ther; 2009; 31 Pt 2():2433-41. PubMed ID: 20110051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.